Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
bioMerieux SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
bioMerieux SA, Medical Equipment Deals By Type, 2011 to YTD 2017 7
bioMerieux SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
bioMerieux SA, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
bioMerieux SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
bioMerieux SA, Medical Equipment, Deal Details 12
Venture Financing 12
Quanterix Raises US$19 Million In Series C Financing 12
Private Equity 14
BioTheranostics Raises USD32 Million in Private Equity Financing 14
Athyrium Opportunities Fund Invests US$20 Million In BioFire Diagnostics 15
Partnerships 16
Quanterix Enters into Licensing Agreement with bioMerieux 16
BioMerieux Enters into Licensing Agreement with Astute Medical 17
Seegene Enters Into Licensing Agreement With BioMerieux For DPO And TOCE Technologies 18
Lonza Walkersville Enters Into Licensing Agreement With Hyglos For Endotoxin Detection Patents 19
bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology 20
Biomerieux Enters into Agreement with Banyan Biomarkers 21
ITL Biomedical Enters into Distribution Agreement with bioMerieux Canada 22
Biotheranostics Enters into Agreement with Syapse 23
BioMerieux Enters into Co-Development Agreement with Copan Italia 24
BioMerieux Enters into Distribution Agreement with Copan 25
BioMerieux Enters into Distribution Agreement with Copan for WASP and WASPLab 26
BioMerieux Enters into Co-Development Agreement with Illumina 27
PathoGenetix And Applied Maths Enter Into Technology Integration Agreement For Pathogen Strain Typing 28
OpGen Enters Into Agreement With Applied Maths To Develop Whole Genome Mapping Software 29
Thermo Fisher Scientific Extends Co-Development Agreement With bioMerieux For Procalcitonin Testing 30
Debt Offering 31
bioMerieux Completes Private Placement Of Bonds Due 2020 For US$406.6 Million 31
Acquisition 32
bioMerieux to Acquire 34% Stake in Sysmex bioMerieux from Sysmex 32
BioMerieux Acquires Applied Maths 33
BioMerieux Completes Acquisition Of BioFire Diagnostics For US$486 Million 34
Biosynex Acquires Dima Gesellschaft Fur Diagnostika, Rapid Diagnostic Tests Maker 36
bioMerieux Completes Acquisition Of AES Laboratoire 37
bioMerieux Acquires Argene 39
bioMerieux SA – Key Competitors 40
bioMerieux SA – Key Employees 41
bioMerieux SA – Locations And Subsidiaries 43
Head Office 43
Other Locations & Subsidiaries 43
Recent Developments 48
Financial Announcements 48
Aug 30, 2017: bioMerieux – First-Half 2017 Results 48
Jul 20, 2017: bioMerieux – Second-Quarter 2017 Business Review 51
Apr 20, 2017: bioMerieux – First-Quarter 2017 Business Review 53
Mar 01, 2017: bioMerieux – 2016 Financial Results 56
Jan 19, 2017: bioMerieux – Fourth-Quarter 2016 Business Review 59
Oct 20, 2016: bioMerieux-Business Review for the nine months ended September 30, 2016 61
Aug 31, 2016: bioMerieux – First-Half 2016 Results 64
Jul 18, 2016: bioMerieux – Second-Quarter 2016 Business Review 68
Apr 20, 2016: bioMérieux – First-Quarter 2016 Business Review 71
Mar 02, 2016: bioMerieux – 2015 Financial Results 73
Jan 21, 2016: bioMerieux – Fourth-Quarter 2015 Business Review 77
Corporate Communications 80
Nov 07, 2016: Pierre Boulud appointed Corporate Vice Presidentof the Asia Pacific region at bioMerieux 80
Product News 81
Jan 05, 2017: Quanterix to Present at The 35th Annual J.P. Morgan Healthcare Conference 81
Oct 10, 2016: bioMerieux: Lyme disease diagnostic tests 82
Oct 06, 2016: bioMerieux introduces EviSight Compact, a new automated diagnostic solution for microbial detection in pharmaceutical productio 83
Jul 06, 2016: bioMerieux enlarges its pathogen identification capability on VITEK MS 84
Other Significant Developments 85
Oct 18, 2017: bioMerieux – Business review for the nine months ended September 30, 2017 85
Oct 10, 2016: BIOASTER, bioMerieux, ESPCI, GSK, Hospices Civils de Lyon and Sanofi join forces against sepsis 87
Aug 08, 2016: ITL contract extended with bioMerieux 89
May 31, 2016: bioMerieux and the Lyon Civil Hospitals strengthen their collaboration and expand their partnership to include Claude Bernard University Lyon 1 90
Mar 22, 2016: bioMérieux and COPAN announce the first commercial success of their collaboration for the automation and efficiency of microbiology laboratories 91
Appendix 92
Methodology 92
About GlobalData 92
Contact Us 92
Disclaimer 92
bioMerieux SA, Medical Equipment, Key Facts, 2016 2
bioMerieux SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
bioMerieux SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
bioMerieux SA, Medical Equipment Deals By Type, 2011 to YTD 2017 7
bioMerieux SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
bioMerieux SA, Deals By Market, 2011 to YTD 2017 9
bioMerieux SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Quanterix Raises US$19 Million In Series C Financing 12
BioTheranostics Raises USD32 Million in Private Equity Financing 14
Athyrium Opportunities Fund Invests US$20 Million In BioFire Diagnostics 15
Quanterix Enters into Licensing Agreement with bioMerieux 16
BioMerieux Enters into Licensing Agreement with Astute Medical 17
Seegene Enters Into Licensing Agreement With BioMerieux For DPO And TOCE Technologies 18
Lonza Walkersville Enters Into Licensing Agreement With Hyglos For Endotoxin Detection Patents 19
bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology 20
Biomerieux Enters into Agreement with Banyan Biomarkers 21
ITL Biomedical Enters into Distribution Agreement with bioMerieux Canada 22
Biotheranostics Enters into Agreement with Syapse 23
BioMerieux Enters into Co-Development Agreement with Copan Italia 24
BioMerieux Enters into Distribution Agreement with Copan 25
BioMerieux Enters into Distribution Agreement with Copan for WASP and WASPLab 26
BioMerieux Enters into Co-Development Agreement with Illumina 27
PathoGenetix And Applied Maths Enter Into Technology Integration Agreement For Pathogen Strain Typing 28
OpGen Enters Into Agreement With Applied Maths To Develop Whole Genome Mapping Software 29
Thermo Fisher Scientific Extends Co-Development Agreement With bioMerieux For Procalcitonin Testing 30
bioMerieux Completes Private Placement Of Bonds Due 2020 For US$406.6 Million 31
bioMerieux to Acquire 34% Stake in Sysmex bioMerieux from Sysmex 32
BioMerieux Acquires Applied Maths 33
BioMerieux Completes Acquisition Of BioFire Diagnostics For US$486 Million 34
Biosynex Acquires Dima Gesellschaft Fur Diagnostika, Rapid Diagnostic Tests Maker 36
bioMerieux Completes Acquisition Of AES Laboratoire 37
bioMerieux Acquires Argene 39
bioMerieux SA, Key Competitors 40
bioMerieux SA, Key Employees 41
bioMerieux SA, Other Locations 43
bioMerieux SA, Subsidiaries 43
【免責事項】
http://www.globalresearch.jp/disclaimer